Abstract:Congenital heart disease (CHD) is the most prevalent type of birth defect in humans and is the leading non-infectious cause of infant death worldwide. There is a growing body of evidence demonstrating that genetic defects play an important role in the pathogenesis of CHD. However, CHD is a genetically heterogeneous disease and the genetic basis underpinning CHD in an overwhelming majority of patients remains unclear. In this study, the coding exons and splice junction sites of the TBX1 gene, which encodes a T-box homeodomain transcription factor essential for proper cardiovascular morphogenesis, were sequenced in 230 unrelated children with CHD. The available family members of the index patient carrying an identified mutation and 200 unrelated ethnically matched healthy individuals used as controls were subsequently genotyped for TBX1. The functional effect of the TBX1 mutation was predicted by online program MutationTaster and characterized by using a dual-luciferase reporter assay system. As a result, a novel heterozygous TBX1 mutation, p.Q277X, was identified in an index patient with double outlet right ventricle (DORV) and ventricular septal defect (VSD). Genetic analysis of the proband's available relatives showed that the mutation co-segregated with CHD transmitted in an autosomal dominant pattern with complete penetrance. The nonsense mutation, which was absent in 400 control chromosomes, altered the amino acid that was completely conserved evolutionarily across species and was predicted to be disease-causing by MutationTaster. Biochemical analysis revealed that Q277X-mutant TBX1 lost transcriptional activating function when compared with its wild-type counterpart. This study firstly associates TBX1 loss-of-function mutation with enhanced susceptibility to DORV and VSD in humans, which provides novel insight into the molecular mechanism underlying CHD and suggests potential implications for the development of new preventive and therapeutic strategies for CHD.

Computed tomographic findings in TBX4 mutation: a common cause of severe pulmonary artery hypertension in children

Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension

Identification of a Novel Mutation in the BMPR2 Gene in a Pulmonary Arterial Hypertension Patient Using Next‐generation Sequencing

Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy

TBX5 Mutations Contribute to Early-Onset Atrial Fibrillation in Chinese and Caucasians.

Neonatal persistent pulmonary hypertension related to a novel TBX4 mutation: case report and review of the literature

Loss of Tbx4 Affects Postnatal Lung Development and Predisposes to Pulmonary Hypertension.

Imaging Features in BMPR2 Mutation-associated Pulmonary Arterial Hypertension

Persistence of persistent pulmonary hypertension of the newborn: a case of de novo TBX4 variant

The Glu86 Residue in TBX4 Proves Critical for Human Lung Development

Molecular genetic framework underlying pulmonary arterial hypertension

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

TBX1 Loss-of-function Mutation Contributes to Congenital Conotruncal Defects

A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

Association between Genotype, Presentation, and Outcome in Childhood Idiopathic and Hereditary Pulmonary Arterial Hypertension

[Genetic, cellular and molecular mechanisms of pulmonary arterial hypertension]

The role and mechanism of thrombospondin-4 in pulmonary arterial hypertension associated with congenital heart disease

Abstract P331: Upregulated TBX1 by Genetic Variants Are Associated with Human Congenital Heart Disease

A Novel Tbx5 Mutation Predisposes To Familial Cardiac Septal Defects And Atrial Fibrillation As Well As Bicuspid Aortic Valve

A New TBX5 Loss-of-Function Mutation Contributes to Congenital Heart Defect and Atrioventricular Block

Novel association of LBX1 mutation with tetralogy of Fallot and hypertrophic cardiomyopathy: implications for cardiac development